SENATE-BILL 1753: S.1753 - End Price Gouging for Medications Act

Overall Constitutional Implications

The bill is likely to improve access to necessary medications for a wide range of individuals, particularly those from economically disadvantaged backgrounds. By establishing reference prices, it seeks to address disparities in healthcare access, which is a significant constitutional concern under the Equal Protection Clause.

Key Individual Rights

• Right to access healthcare
• Equal protection under the law
• Due process rights of pharmaceutical companies

Constitutional Provisions

• Equal Protection Clause (14th Amendment)
• Commerce Clause (Article I, Section 8)
• Due Process Clause (14th Amendment)

Potential Constitutional Challenges

While the bill supports individual rights by promoting equitable access to medications, it may face legal challenges from pharmaceutical companies regarding due process rights and the regulation of drug pricing. These companies could argue that the imposed reference prices infringe upon their ability to set prices freely.

Summary

SENATE-BILL 1753 has the potential to significantly enhance individual rights by making prescription medications more affordable and accessible, particularly for vulnerable populations such as low-income individuals, seniors, and racial minorities. However, it also raises important constitutional questions regarding the balance between regulating drug prices and protecting the rights of pharmaceutical companies.